The Nose Knows: Why NeOnc’s Patent Portfolio Could Make NTHI More Than a One-Drug Biotech
Go back to The Nose Knows: Why NeOnc’s Patent Portfolio Could Make NTHI More Than a One-Drug Biotech| (NASDAQ: NTHI) | Delayed: 3.45 +0.12 (3.60%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.33 | 52 Week High | $ | |||
| Open | $3.34 | 52 Week Low | $ | |||
| Day High | $3.45 | P/E | N/A | |||
| Day Low | $3.31 | EPS | $ | |||
| Volume | 12,676 | |||||

